Newer Migraine Drugs Reduce Headache Days With Fewer Side Effects, Study Finds

• May 5, 2026
• HealthDayTV HealthDay Reporter

A review in Annals of Internal Medicine finds most CGRP-targeted therapies cut migraine days by about two per month. Evidence for older medications was weaker, according to researchers.

Health News is provided as a service to Pelham Pharmacy site users by HealthDay. Pelham Pharmacy nor its employees, agents, or contractors, review, control, or take responsibility for the content of these articles. Please seek medical advice directly from your pharmacist or physician.

Copyright © 2026 HealthDay All Rights Reserved.

Tags